Prednisone inhibits osteosarcoma cell by regulating the Wnt/β-catenin signaling pathway

Prednisone, a synthetic glucocorticoid, possesses a moderate duration of action in the human body. To investigate the effect of prednisone on osteosarcoma cells in vitro, CCK8, wound healing, Transwell assays, flow-cytometry, western blot, and ELISA were used to measure cell proliferation, cell mig...

Full description

Saved in:
Bibliographic Details
Main Authors: Yo Zhang, Hongmei Zhang, Shanshan Yang, Xiufeng Gao, Wenhao Guo
Format: Article
Language:English
Published: Bangladesh Pharmacological Society 2024-12-01
Series:Bangladesh Journal of Pharmacology
Subjects:
Online Access:https://www.banglajol.info/index.php/BJP/article/view/76379
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832571082554474496
author Yo Zhang
Hongmei Zhang
Shanshan Yang
Xiufeng Gao
Wenhao Guo
author_facet Yo Zhang
Hongmei Zhang
Shanshan Yang
Xiufeng Gao
Wenhao Guo
author_sort Yo Zhang
collection DOAJ
description Prednisone, a synthetic glucocorticoid, possesses a moderate duration of action in the human body. To investigate the effect of prednisone on osteosarcoma cells in vitro, CCK8, wound healing, Transwell assays, flow-cytometry, western blot, and ELISA were used to measure cell proliferation, cell migration, cell invasion, cell cycle, cell apoptosis, and the key proteins in Wnt/β-catenin pathway. The results showed prednisone could inhibit the proliferation in osteosarcoma cells and exhibit lower proliferation toxicity towards normal bone cells compared to cisplatin by 17.5% (p<0.001). Cell apoptosis was increased by 6.6 and 7.4%, cell migration was decreased to 62.6 and –23.9%, G0/G1 phase cells were increased by 33.0 and 17.9%, and S phase cells were reduced by 29.6 and 18.0% (all p<0.001) in Mg63 and Saos-2 cells respectively after prednisone treatment. The expressions of β-catenin, cMYC, cyclin D1, and MMP7 were also reduced. In conclusion, prednisone inhibits osteosarcoma cells by regulating the Wnt/β-catenin signaling pathway.
format Article
id doaj-art-2afe32d8d7244ffcb1ec73bea320d06d
institution Kabale University
issn 1991-0088
language English
publishDate 2024-12-01
publisher Bangladesh Pharmacological Society
record_format Article
series Bangladesh Journal of Pharmacology
spelling doaj-art-2afe32d8d7244ffcb1ec73bea320d06d2025-02-02T13:09:58ZengBangladesh Pharmacological SocietyBangladesh Journal of Pharmacology1991-00882024-12-0119310.3329/bjp.v19i3.76379Prednisone inhibits osteosarcoma cell by regulating the Wnt/β-catenin signaling pathwayYo Zhang0https://orcid.org/0009-0007-6550-1358Hongmei Zhang1https://orcid.org/0009-0009-3152-9154Shanshan Yang2https://orcid.org/0009-0005-8318-9666Xiufeng Gao3https://orcid.org/0000-0002-2846-0741Wenhao Guo4https://orcid.org/0000-0002-5342-7695Clinical Translational Innovation Center/Molecular Medicine Research Center, West China Hospital, Sichuan University, Chengdu, Sichuan Province, China.Clinical Translational Innovation Center/Molecular Medicine Research Center, West China Hospital, Sichuan University, Chengdu, Sichuan Province, China.Clinical Translational Innovation Center/Molecular Medicine Research Center, West China Hospital, Sichuan University, Chengdu, Sichuan Province, China.West China School of Basic Medical Sciences and Forensic Medicine, Sichuan University, Chengdu, Sichuan Province, China..Department of Abdominal Oncology, Cancer Center and State Key Laboratory of Biotherapy, Medical School, West China Hospital, Sichuan University, Sichuan Province, China. Prednisone, a synthetic glucocorticoid, possesses a moderate duration of action in the human body. To investigate the effect of prednisone on osteosarcoma cells in vitro, CCK8, wound healing, Transwell assays, flow-cytometry, western blot, and ELISA were used to measure cell proliferation, cell migration, cell invasion, cell cycle, cell apoptosis, and the key proteins in Wnt/β-catenin pathway. The results showed prednisone could inhibit the proliferation in osteosarcoma cells and exhibit lower proliferation toxicity towards normal bone cells compared to cisplatin by 17.5% (p<0.001). Cell apoptosis was increased by 6.6 and 7.4%, cell migration was decreased to 62.6 and –23.9%, G0/G1 phase cells were increased by 33.0 and 17.9%, and S phase cells were reduced by 29.6 and 18.0% (all p<0.001) in Mg63 and Saos-2 cells respectively after prednisone treatment. The expressions of β-catenin, cMYC, cyclin D1, and MMP7 were also reduced. In conclusion, prednisone inhibits osteosarcoma cells by regulating the Wnt/β-catenin signaling pathway. https://www.banglajol.info/index.php/BJP/article/view/76379OsteosarcomaPrednisoneWestern blotWnt/β-catenin signaling
spellingShingle Yo Zhang
Hongmei Zhang
Shanshan Yang
Xiufeng Gao
Wenhao Guo
Prednisone inhibits osteosarcoma cell by regulating the Wnt/β-catenin signaling pathway
Bangladesh Journal of Pharmacology
Osteosarcoma
Prednisone
Western blot
Wnt/β-catenin signaling
title Prednisone inhibits osteosarcoma cell by regulating the Wnt/β-catenin signaling pathway
title_full Prednisone inhibits osteosarcoma cell by regulating the Wnt/β-catenin signaling pathway
title_fullStr Prednisone inhibits osteosarcoma cell by regulating the Wnt/β-catenin signaling pathway
title_full_unstemmed Prednisone inhibits osteosarcoma cell by regulating the Wnt/β-catenin signaling pathway
title_short Prednisone inhibits osteosarcoma cell by regulating the Wnt/β-catenin signaling pathway
title_sort prednisone inhibits osteosarcoma cell by regulating the wnt β catenin signaling pathway
topic Osteosarcoma
Prednisone
Western blot
Wnt/β-catenin signaling
url https://www.banglajol.info/index.php/BJP/article/view/76379
work_keys_str_mv AT yozhang prednisoneinhibitsosteosarcomacellbyregulatingthewntbcateninsignalingpathway
AT hongmeizhang prednisoneinhibitsosteosarcomacellbyregulatingthewntbcateninsignalingpathway
AT shanshanyang prednisoneinhibitsosteosarcomacellbyregulatingthewntbcateninsignalingpathway
AT xiufenggao prednisoneinhibitsosteosarcomacellbyregulatingthewntbcateninsignalingpathway
AT wenhaoguo prednisoneinhibitsosteosarcomacellbyregulatingthewntbcateninsignalingpathway